Pathogenic significance of α-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus

Microbes and Infection

Volumn 7, Issue 4, 2005, Pages 674-681

  Yamamoto, Nobuto ^a   Urade, Masahiro ^b  

^a Socrates Institute for Therapeutic Immunology   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

N acetylgalactosaminidase; Fusion; HA protein; Immunosuppression; Proteolytic activation; Vitamin D binding protein (Gc protein)

Indexed keywords

ALPHA N ACETYLGALACTOSAMINIDASE; DEOXYCHOLATE SODIUM; HEMAGGLUTININ; TRYPSIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; IMMUNE DEFICIENCY; INFLUENZA VIRUS A; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRION; VIRUS HEMAGGLUTINATION;

ALPHA-N-ACETYLGALACTOSAMINIDASE; ANIMALS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; VITAMIN D-BINDING PROTEIN;

INFLUENZA VIRUS;

EID: 19344363867     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.01.015     Document Type: Article

References (42)

1. L. Old, B. Benacerraf, D.A. Clark, and H. Goldsmith The reticuloendothelial system and neoplastic process Ann. NY Acad. Sci. 88 1960 264 280
2. 3H mice Proc. Soc. Exp. Biol. Med. 114 1960 517 520
3. S. Specter, and H. Friedman Viruses and the immune response Pharmac. Ther. A, 2 1978 595 622
4. S.M. Schnittman, M.C. Psallidopoulos, H.C. Lane, L. Thompson, M. Baseler, and F. Massari The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4 Science 245 1989 305 308
5. C.V. Pirquet Das Verhalten der Kutnen Tuberkulin-reaction waehrend der Masern Deutsche Medizinische Wochenshrift 30 1908 1297 1300
6. A.L. Bloomfield, and J.G. Mateer Changes in skin sensitiveness to tuberculin during epidemic influenza Am. Rev. Tuber. 3 1919 166 168
7. A. Szentivanyi H. Friedman Viruses, Immunity and Immunodeficiency 1986 Plenum Press New York
8. F.M. Burnet The concept of immunological surveillance Prog. Exp. Tumor Res. 13 1970 1 27
9. A.G. Dalgleish, P.C. Beverly, P.R. Clapham, D.H. Crawford, W.F. Greaves, and R.A. Weiss The CD4 (T4) antigen is an essential component of receptor for the AIDS retrovirus Nature 312 1984 763 767
10. E.D. Kilbourne Influenza as a problem in immunology J. Immunol. 12 1978 1447 1452
11. C. Sweet, and H. Smith Pathogenicity of influenza virus Microbiol. Rev. 44 1980 303 330
12. R.B. Couch The effects of influenza on host defenses J. Infect. Dis. 144 1981 284 291
13. A. Crosby America's Forgotten Pandemic 1989 Cambridge University Press Cambridge, UK
14. L.A. Babiuk, L.J.P. Lawman, and H.B. Ohmann Viral-bacterial synergistic interaction in respiratory disease Adv. Virus Res. 35 1988 219 249
15. D. Warshauer, E. Goldstein, T. Akers, W. Lippert, and M. Kim Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages Am. Rev. Respir. Dis. 115 1977 269 277
16. N. Yamamoto, and N.Z. Ngwenya Activation of macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids Cancer Res. 47 1987 2008 2013
17. 3 binding protein (group-specific component, Gc) is a precursor for the macrophage activating signal factor from lysophosphatidylcholine-treated lymphocytes Proc. Natl. Acad. Sci. USA 88 1991 8539 8543
18. B.Z. Ngwenya, and N. Yamamoto Contribution of lysophosphatidylcholine- treated nonadherent cells to mechanism of macrophage activation Proc. Soc. Exp. Biol. Med. 193 1990 118 124
19. 3-binding protein and albumin Infect. Immun. 61 1993 5388 5391
20. 3 binding protein with adjuvant activity for antibody production Mol. Immunol. 33 1996 1157 1164
21. 3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells J. Immunol. 151 1993 2794 2802
22. 3 binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages J. Immunol. 147 1991 273 280
23. N. Yamamoto, N.P. Willett, and D.D. Lindsay Participation of serum proteins in the inflammation-primed activation of macrophages Inflammation 18 1994 311 322
24. 3-binding protein and immunosuppression in HIV-infected patients AIDS Res. Hum. Retrov. 11 1995 1373 1378
25. N. Yamamoto, V.R. Naraparaju, and S.O. Asbell Deglycosylation of serum vitamin D-binding protein and immunosuppression in cancer patients Cancer Res. 56 1996 2827 2831
26. 3-sepharose chromatography Anal. Biochem. 157 1986 262 269
27. N. Yamamoto, V.R. Naraparaju, and M. Urade Prognostic utility of serum α-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients Cancer Res. 57 1997 295 299
28. F. Yagi, A.E. Eckhardt, and I.J. Goldstein Glycosidases of Ehrlich ascites tumor cells and ascitic fluid-purification and substrate specificity of α-N-acetylgalactosaminidase and α-galactosidase: comparison with coffee bean α-galactosidase Arch. Biochem. Biophys. 280 1990 61 67
29. A.P. Kendal, W.R. Dowdle, and G.R. Noble Influenza viruses E.H. Lennette Manual of Clinical Microbiology 1985 American Society for Microbiology Washington, DC 755 762
30. M.J. Hayman, J.J. Skehel, and M.J. Crumpton Purification of viral glycoprotein by affinity chromatography using Lens culinaris phytohaemagglutinin FEBS Lett. 29 1973 185 188
31. D.H. Coppenhaver, N.P. Sllenne, and B.H. Bowman Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component) Arch. Biochem. Biophys. 226 1983 218 223
32. M. Viau, J. Constans, H. Debray, and J. Motreuil Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein Biochem. Biophys. Res. Commun. 117 1983 324 331
33. M.D. Waterfield, K. Espelie, and K. Elder Structure of the haemagglutinin of influenza virus Br. Med. Bull. 35 1979 57 63
34. M. Marsh, and A. Dalgleish How do human immunodeficiency viruses enter cells? Immunol. Today 8 1987 369 371
35. H.D. Klenk, R. Rott, M. Orlich, and J. Blodorn Activation of influenza A viruses by trypsin treatment Virology 68 1975 426 439
36. S.G. Lazarowitz, and P.W. Choppin Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide Virology 68 1975 440 454
37. D.J. Gloeb, S. Lai, J. Efantis, and M.J. O'Sullivan Survival and disease progression in human immunodeficiency virus-infected women after an index delivery Am. J. Obst. Gynecol. 167 1992 152 157
38. M. Stein, P. O'Sullivan, T. Wachtel, A. Fisher, D. Mikolich, and S. Sepe Causes of death in persons with human immunodeficiency virus infection Am. J. Med. 93 1992 387 390
39. 3-binding protein-derived macrophage activating factor on Ehrlich tumor bearing mice Proc. Soc. Exp. Biol. Med. 220 1999 20 26
40. 3-binding protein-derived macrophage activating factor Cancer Res. 57 1997 2187 2192
41. N. Yamamoto, Diagnostic and prognostic ELISA assays of serum α-N-acetylgalactosaminidase for AIDS, US Patent (1999) No. 5,985,545.
42. J.J. Skehel, P.M. Bayley, E.B. Brown, S.R. Martin, M.D. Waterfield, and J.M. White Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion Proc. Natl. Acad. Sci. USA 79 1982 968 972